Thyssenkrupp’s Mixed Signals: Submarine Orders Soar While Green Hydrogen Ambitions Cool

The industrial conglomerate’s latest guidance update tells two very different stories — one of military shipbuilding momentum, the other of a costly retreat from a once-promising clean energy technology.

Shares in Thyssenkrupp have been on a remarkable run this year, climbing 42 percent since January and trading more than 86 percent above their 52-week low of 7.10 euros. Yet the path higher has been anything but smooth, with investors forced to weigh booming defence orders against a strategic pullback in the group’s hydrogen division.

A Guidance Lift Built on Naval Strength

Management raised its full-year adjusted EBIT outlook to at least 600 million euros, up from a previous target of 500 million euros, after third-quarter results came in ahead of internal expectations. Revenue for the period reached 8.79 billion euros, beating market forecasts, though adjusted EBIT of 183 million euros — an 18 percent year-on-year improvement — fell short of the 207 million euros analysts had pencilled in.

The headline numbers capture a group that is growing but not yet earning as much as the market hoped. Still, the decision to lift guidance signals confidence in the quarters ahead.

The engine of that optimism is the naval subsidiary TKMS. The defence contractor raised its full-year revenue growth forecast to between 10 and 12 percent, a substantial upgrade from the 2 to 5 percent previously anticipated, with its EBIT margin expected to reach as high as 6.5 percent.

Over the first nine months, TKMS delivered revenue growth of 19 percent to 1.89 billion euros, while adjusted EBIT rose 13 percent to 110 million euros. The order book stood at 20.1 billion euros at the balance sheet date, and a subsequent contract for four MEKO A-200 frigates added another 6.3 billion euros, pushing total orders beyond 25 billion euros. Management expects additional orders exceeding 5 billion euros in the fourth quarter alone.

The Canadian submarine programme adds further upside: TKMS has been named preferred bidder for up to twelve Type 212CD boats, with contract signing targeted before year-end.

The Hydrogen Pullback

The counterweight to that defence-driven optimism is Thyssenkrupp Nucera, the group’s water electrolysis subsidiary. The decision to exit SOEC series production has forced a roughly 30 million euro writedown in the fourth quarter and a revision of Nucera’s full-year EBIT forecast to between 75 and 105 million euros — a curious adjustment, given the previous range was 30 to 80 million euros.

Should investors sell immediately? Or is it worth buying Thyssenkrupp?

The unit’s nine-month figures reveal the underlying strain. While order intake nearly doubled to 471 million euros from 241 million euros a year earlier — with green hydrogen orders surging from 23 million to 184 million euros — revenue in that segment collapsed from 377 million to 80 million euros. The operating result deteriorated to minus 107 million euros from minus 39 million euros.

Group-wide, Nucera reported nine-month revenue down from 663 million to 354 million euros, with EBIT at minus 69 million euros.

The gap between swelling orders and shrinking revenue raises legitimate questions about when — or whether — the hydrogen growth story translates into profitability. Management expects the SOEC exit to generate a positive EBIT effect of 10 million euros and a cash flow benefit of 20 million euros next fiscal year, but the immediate optics are sobering.

Market Reaction and Positioning

The market’s response to the Nucera news was swift: shares fell 4.6 percent on the day to 13.27 euros, a decline amplified by a broader risk-off session in which rising bond yields weighed on European technology and industrial stocks. Siemens Energy, another name exposed to the energy transition theme, also lost ground.

That single-day drop, however, sits within a longer trend that remains firmly positive. The stock recently traded at 13.23 euros, just below the prior close, and remains 5.9 percent shy of its 52-week high of 14.05 euros reached on 17 August.

Institutional backing appears to be firming. Asset manager Amundi reported raising its voting rights to 4.82 percent in late July, or 5.06 percent including instruments — a signal that at least some large investors see value in the conglomerate’s ongoing restructuring.

For shareholders, the central tension is clear: a defence business with a bulging order book and rising margins sits alongside a hydrogen unit that has retreated from a key technology just as its order momentum was building. Whether the fourth-quarter results resolve that contradiction — or deepen it — will determine whether the stock’s impressive year-to-date gains have further to run.